FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909386810> ?p ?o ?g. }

• W2909386810 endingPage "66" @default.
• W2909386810 startingPage "57" @default.
• W2909386810 abstract "The materials on psychological and psychosocial status of women with HIV and HCV co-infection [1] with the following assessment of their readiness and ability to undergo treatment of chronic hepatitis C virus and maintenance of treatment compliance to antiretroviral therapy of HIV. The objective of the survey: analysis of the clinical and somatic status of women with HIV and HCV co-infection with the following assessment of their ability to antiviral therapy of CHC and maintenance of treatment compliance to ART taking into account their health status. Materials and methods: the check-up of 100 surveyed women with HIV and HCV co-infection taking into account epidemiologic evidence, laboratory parameters: immunologic (CD4 lymphocyte count), virological (HIV and VHC RNA, VHC genotype) and complete and biochemical blood count was made. Medical prescriptions and response to treatment of CHC were analyzed taking into account the drugs used. Results. Mean age of patients was 36±6 years. Most women had a long-standing co-infection. 1% of women were in the subclinical stage of HIV infection, 64% had stage 4A, 4B — 14% and 4B — 11%. The number of CD4 lymphocytes was 494±29 cells/μl. 78% received ART, and 85% of women showed a high rate of treatment compliance. Among the prevalent HIV-associated diseases were candidiasis (62%), viral (7%) and bacterial diseases (3%); a high percentage (15%) of past tuberculosis of various localization was noted. In 45 cases (53%), HCV RNA was detected in the blood. According to the results of liver elastometry, 74,4% had minimal and moderate fibrosis (METAVIR ≤F2), and a quarter of patients had marked fibrosis (METAVIR F3-F4). Antiviral therapy of chronic hepatitis C was performed in 24% of 100 surveyed women. 62,5% received the combination of pegylated interferon and ribavirin, in 86,6% of cases a sustained virological response was achieved. Treatment with direct antiviral agents was performed in 5 patients, in all cases a sustained virological response was achieved. 85% of patients showed total bilirubin level within the normal range, alanine aminotransferase and aspartate aminotransferase were moderately increased in 41% of women. Most (67,7%) revealed diffuse changes in the structure of the liver, and 36% had pancreatic diffuse changes. Hepatomegaly was found in 24% of cases and splenomegaly was found in 13,3% of women. Comorbid infectious and non-infectious diseases were diagnosed in 59% of women: 32,2% — diseases of the digestive system, 20,3% — diseases of the urogenital system and 18,6% — diseases of the respiratory system. Diseases of the nervous system were diagnosed in 70% of women. Conclusion. The somatic state of women with HIV/HCV co-infection in almost all cases was quite stable, the comorbid pathology was in remission, which gives grounds for expanding indications for prescribing antiviral therapy for CHC. However, many patients are not inclined to undergo treatment with interferon-containing regimens due to the duration of the course and poor tolerance, some of them are focused on treatment with direct-acting antiviral agents and are looking for such a possibility outside the hospital. Therapy with direct-acting antiviral agents with a small number of side effects and high efficacy is a priority for women with HIV/HCV co-infection." @default.
• W2909386810 created "2019-01-25" @default.
• W2909386810 creator A5011020354 @default.
• W2909386810 creator A5015010885 @default.
• W2909386810 creator A5054677365 @default.
• W2909386810 creator A5063073669 @default.
• W2909386810 creator A5065402340 @default.
• W2909386810 creator A5074637793 @default.
• W2909386810 creator A5078939338 @default.
• W2909386810 creator A5082354544 @default.
• W2909386810 date "2019-01-16" @default.
• W2909386810 modified "2023-10-03" @default.
• W2909386810 title "WOMEN CO-INFECTED WITH HIV AND VHC. PART 2. CLINICAL STATUS AND READINESS TO ANTIVIRAL THERAPY" @default.
• W2909386810 cites W1524759255 @default.
• W2909386810 cites W1991319605 @default.
• W2909386810 cites W2554121084 @default.
• W2909386810 cites W2556001194 @default.
• W2909386810 cites W2731389322 @default.
• W2909386810 cites W2782722181 @default.
• W2909386810 cites W2895557218 @default.
• W2909386810 doi "https://doi.org/10.22328/2077-9828-2018-10-4-57-66" @default.
• W2909386810 hasPublicationYear "2019" @default.
• W2909386810 type Work @default.
• W2909386810 sameAs 2909386810 @default.
• W2909386810 citedByCount "2" @default.
• W2909386810 countsByYear W29093868102020 @default.
• W2909386810 countsByYear W29093868102022 @default.
• W2909386810 crossrefType "journal-article" @default.
• W2909386810 hasAuthorship W2909386810A5011020354 @default.
• W2909386810 hasAuthorship W2909386810A5015010885 @default.
• W2909386810 hasAuthorship W2909386810A5054677365 @default.
• W2909386810 hasAuthorship W2909386810A5063073669 @default.
• W2909386810 hasAuthorship W2909386810A5065402340 @default.
• W2909386810 hasAuthorship W2909386810A5074637793 @default.
• W2909386810 hasAuthorship W2909386810A5078939338 @default.
• W2909386810 hasAuthorship W2909386810A5082354544 @default.
• W2909386810 hasBestOaLocation W29093868101 @default.
• W2909386810 hasConcept C113280763 @default.
• W2909386810 hasConcept C118552586 @default.
• W2909386810 hasConcept C126322002 @default.
• W2909386810 hasConcept C142462285 @default.
• W2909386810 hasConcept C146357865 @default.
• W2909386810 hasConcept C150966472 @default.
• W2909386810 hasConcept C151730666 @default.
• W2909386810 hasConcept C203014093 @default.
• W2909386810 hasConcept C2426938 @default.
• W2909386810 hasConcept C2522874641 @default.
• W2909386810 hasConcept C2776408679 @default.
• W2909386810 hasConcept C2776455275 @default.
• W2909386810 hasConcept C2993512173 @default.
• W2909386810 hasConcept C3013748606 @default.
• W2909386810 hasConcept C3020491458 @default.
• W2909386810 hasConcept C71924100 @default.
• W2909386810 hasConcept C86803240 @default.
• W2909386810 hasConcept C98274493 @default.
• W2909386810 hasConceptScore W2909386810C113280763 @default.
• W2909386810 hasConceptScore W2909386810C118552586 @default.
• W2909386810 hasConceptScore W2909386810C126322002 @default.
• W2909386810 hasConceptScore W2909386810C142462285 @default.
• W2909386810 hasConceptScore W2909386810C146357865 @default.
• W2909386810 hasConceptScore W2909386810C150966472 @default.
• W2909386810 hasConceptScore W2909386810C151730666 @default.
• W2909386810 hasConceptScore W2909386810C203014093 @default.
• W2909386810 hasConceptScore W2909386810C2426938 @default.
• W2909386810 hasConceptScore W2909386810C2522874641 @default.
• W2909386810 hasConceptScore W2909386810C2776408679 @default.
• W2909386810 hasConceptScore W2909386810C2776455275 @default.
• W2909386810 hasConceptScore W2909386810C2993512173 @default.
• W2909386810 hasConceptScore W2909386810C3013748606 @default.
• W2909386810 hasConceptScore W2909386810C3020491458 @default.
• W2909386810 hasConceptScore W2909386810C71924100 @default.
• W2909386810 hasConceptScore W2909386810C86803240 @default.
• W2909386810 hasConceptScore W2909386810C98274493 @default.
• W2909386810 hasIssue "4" @default.
• W2909386810 hasLocation W29093868101 @default.
• W2909386810 hasOpenAccess W2909386810 @default.
• W2909386810 hasPrimaryLocation W29093868101 @default.
• W2909386810 hasRelatedWork W1762327303 @default.
• W2909386810 hasRelatedWork W2032294507 @default.
• W2909386810 hasRelatedWork W2059818506 @default.
• W2909386810 hasRelatedWork W2164885820 @default.
• W2909386810 hasRelatedWork W2389439455 @default.
• W2909386810 hasRelatedWork W2439078362 @default.
• W2909386810 hasRelatedWork W2563019825 @default.
• W2909386810 hasRelatedWork W2947890551 @default.
• W2909386810 hasRelatedWork W3029134734 @default.
• W2909386810 hasRelatedWork W3128706561 @default.
• W2909386810 hasVolume "10" @default.
• W2909386810 isParatext "false" @default.
• W2909386810 isRetracted "false" @default.
• W2909386810 magId "2909386810" @default.
• W2909386810 workType "article" @default.